Gilead acquires Ouro Medicines in multibillion deal securing China linked antibody therapy rights

Gilead Sciences has agreed to acquire US based biotech firm Ouro Medicines in a deal valued at up to 2.18 billion dollars, gaining access to a promising antibody based treatment originally licensed from China’s Keymed Biosciences. The transaction highlights the growing importance of

AstraZeneca Deepens China Bet With Major Expansion Plan

AstraZeneca has unveiled a 15 billion dollar investment plan in China, underscoring renewed commercial momentum between Beijing and London as the UK prime minister visits the country. The British Swedish pharmaceutical group said the investment, running through 2030, will expand medicines manufacturing and

Two Big Drug Flops Show How Health-Care Economics Have Changed

Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion.